Henri Steenkamp
Analyst · Ladenburg. Your line is open
Thank you, Chris. Looking at our quarterly key performance metrics on Slide 4, we see that for the quarter ended November 30, 2016, our net investment income was $3.4 million or $0.60 on a weighted average per share basis. Adjusted for the incentive fee accrual related to net unrealized capital gains in the second incentive fee calculation, our net investment income was $3.0 million or $0.53 per share. This represents that an increase of $0.7 million compared to the same period last year and no change compared to the quarter end at August 31, 2016. For this year’s third quarter, total investment income was $8.4 million, essentially the same as compared to this year’s second quarter and an increase of 21.7% from $6.9 million for the same quarterly period last year. This increased investment income was generated from an investment base that has grown by 15% from the third quarter last year and by 2% on a sequential quarterly basis. In addition, total investment income benefited from an increase of $0.3 million in other income this quarter compared to last year as the higher levels of originations and repayments this quarter led to increased advisory fees and prepayment penalties received. As compared to last year’s third quarter, the investment income increase was offset by; one, increased debt and financing expenses from higher outstanding notes payable and SBA debentures this year, reflective of the growing average investment in asset base. And two, slightly increased base and incentive management fees generated from the management of this larger pool of investments. Finally, net investment income this quarter benefited from decreased total expenses, excluding interest and debt financing expenses, base management fees and incentive fees, reflecting primarily lower general and administrative expenses. As compared to this year’s second quarter’s debt and financing expenses, base and incentive management fees and general, administrative expenses, were relatively unchanged. In the third quarter of fiscal 2017, we experienced a net loss on investments of $1.8 million or $0.52 on a weighted average per share basis, resulting in a total increase in net assets from operations of $1.6 million or $0.27 per share. The $1.8 million net loss on investments was largely comprised of $0.3 million of net realized gains, offset by $2.1 million of net unrealized depreciation. The net unrealized depreciation for the quarter is primarily due to $0.9 million unrealized depreciation on our CLO investment due to increased financing costs and fees related to the refinancing of our CLO in November as well as $0.7 million unrealized depreciation on our Taco Mac investment, reflecting declining fundamentals of that investment. With regards to the CLO depreciation, it is important to note that the depreciation is net of $1.66 million distribution that was received by the BDC this past quarter. Net investment income yield as a percentage of average net asset value was 10.7% for the quarter ended November 30, 2016. Adjusted for the incentive fee accrual related to net unrealized capital gains, the net investment income yield was 9.5%, up from 7.4% for the same period last year while remaining unchanged on a sequential quarter-over-quarter basis. In addition to the appropriate focus on net investment income, we also highlight our return on equity as an important performance indicator, which includes both realized and unrealized gains. Annualized return on equity was 4.9% for this quarter due to the unrealized depreciation mentioned above. This is down from 16.5% last quarter and 10.8% for the same period last year. Importantly, our last 12 months’ ROE is 7.7%, which is significantly beating the current BDC industry average of 1.1%. And as Chris mentioned earlier, excluding the $5.7 million realized and unrealized losses in our two legacy investments, Targus Group International and Elyria Foundry Company LLC, the return on equity for the last 12 months ended November 30, 2016, was 12.1%. Both Targus and Elyria are legacy investments that predate Saratoga’s management of the company. We believe our strong track record of ROE growth is an important indicator of our success in pursuing our strategy of growing the asset base, building scale and generating competitive yield while continuing to focus on the quality of our portfolio. Our total operating expenses were $5.0 million for the third quarter and consisted of $2.4 million in interest and debt financing expenses, $1.6 million in base and incentive management fees, $0.7 million in professional fees and administrative expenses and $0.4 million in insurance expenses, Directors fees and general, administrative and other expenses. For the fiscal third quarter of 2017, total operating expenses increased by $0.2 million as compared to the same period last year. This increase was primarily due to higher base and – base management fee and higher interest and credit facility financing expenses this year, reflecting our growing asset base. Total expenses, excluding interest and debt financing expenses, base management fees and incentive management fees, decreased from $1.2 million for the quarter ended November 30, 2015, to $1.0 million for this past quarter. [Technical Difficulty] total assets both quarters, we expect to further benefit from scale as our assets continue to increase while our cost structure remains relatively consistent. Overall, our ROE and other financial performance measures continued to improve long-term as the benefits of scale become more visible and our operating expenses stabilize and diminish as a percentage of our total assets. Moving on to Slide 5, this is a new waterfall slide we are presenting for the first time and helps reconcile the major changes in NII and NAV per share on a sequential quarterly basis as it is generally only a couple of items that drive the changes period-over-period. Starting at the top of this slide and looking at NII per share. Although it remained unchanged at $0.53 per share from Q2 to Q3, the significant movements were a $0.02 increase in total interest income, offset by a $0.02 reduction in other income, resulting in an unchanged NII per share. At the slide footnotes, operating expenses and a lower weighted average shares outstanding had a very minimal impact and all changes are shown net of incentive fees. Moving to the lower half of this slide, this part reconciles NAV per share from $22.39 at Q2 to $22.21 this quarter. The major changes are due to $0.59 generated by our NII for the quarter, offset by a $0.52 net appreciation of investment. In addition to these changes, NAV per share was further reduced by the $0.44 Q2 dividend declared and $0.02 dilution from an increased share count, offset by a $0.01 positive impact from our stock dividend and share repurchase plan. As you can see on Slide 6, net asset value has steadily increased since 2011, continuing to benefit from the history of consistent realized gains we will discuss later. NAV this quarter was $127.7 million as of November 30, 2016, a $0.9 million decrease from an NAV of $128.6 million for the quarter ended August 31, 2016, but up $2.6 million from an NAV of $125.1 million as of year end. NAV per share was $22.21 as of quarter end compared to $22.39 as of August 31, 2016 and $22.06 as of February 29, 2016. During the past 9-month period, NAV per share increased by $0.15 per share primarily reflecting the $10.1 million or $0.28 per share increase in net assets, which is net of the $1.48 per share dividend paid during the 9-month period. This was offset by the dilutive impact of the net 76,020 shares issued during the 9-month period, representing 1.3% of the shares outstanding. These shares consisted of 264,994 shares issued pursuant to the dividend reinvestment plan, representing three quarters’ dividend payment and a special dividend offset by 188,974 shares that were repurchased. Slide 7 outlines the dry powder available to us as of November 30, 2016. As of this date, we had zero outstanding in borrowings and our revolving credit facility with Madison Capital and $112.7 million in outstanding SBA debentures. Our existing baby bonds have been refinanced subsequent to quarter end and had a carrying amount and fair value of $61.8 million and $62.3 million respectively. With the $45 million available on the credit facility, $37.3 million additional borrowing capacity at our SBIC subsidiary and $23.3 million in cash and cash equivalents, primarily in our SBIC subsidiary, we had a total of $105.6 million of available liquidity at our disposal as of the end of our third quarter 2017. Including the incremental cash from our 2023 baby bonds offering completed in December, this available liquidity increases to $115.6 million, meaning we can grow our current assets under management by a further 42% without any additional external financing. As we demonstrated subsequent to quarter end with the refinancing of our existing baby bonds, we continued to assess all our various capital and liquidity sources and will manage our sources and uses on a real-time basis to ensure optimization. This baby bonds issuance highlights the importance we place on extending the maturity of our capital structure and reducing the weighted average cost of capital, both of which are achieved through this new issuance. We remain pleased with our liquidity position especially taking into account the overall conservative composition of our balance sheet and the ability we continue to have to substantially grow our assets without the need for external financing. To that end, on December 31, 2016, we issued $74.5 million in aggregate principal amount of 6.75% fixed rate notes due 2023 for net proceeds of approximately $72 million after deducting underwriting commissions and offering costs. The issuance included the exercise of substantially all of the underwriter’s option to purchase an additional $9.8 million aggregate principal amount of 2023 notes within 30 days. The proceeds from the offering will be used to repay all of the outstanding indebtedness under the existing 2020 notes, which amounts to $61.8 million. The redemption date is tomorrow. The accounting impact of the baby bonds issuance in Q4 is highlighted on Slide 8. There will be two non-recurring financial impacts related to the baby bonds refinancing. First, there will be a write-down of deferred financing costs related to the previous baby bonds and ATM program of approximately $1.6 million. This will be disclosed as a loss on extinguishment of debt in the income statement. And second, there will be an additional interest expense related to the capital management decision to only call the 2020 bonds once the 2023 bonds had been issued. We perpetually delayed the calling of our existing bonds until the new bonds were issued. The required call period is 30 days and we expect the approximate impact of this additional interest while having both baby bond issuances outstanding to be approximately $400,000 in Q4. We are very pleased with this refinancing, not only does it increase our liquidity base and extend the maturity by almost 4 years, but also locks in a reduction in interest rate of 75 basis points in a rising interest rate environment. Now, I would like to move on to Slides 9 through 11 and review the composition and yields of our investment portfolio. Slide 9 highlights the portfolio composition and yields at the end of the quarter. As of November 30, 2016, the fair value of the company’s investment portfolio was $278 million principally invested in 30 portfolio companies and 1 CLO fund. Saratoga Investment’s portfolio was composed of 57.8% of first-lien term loans, 28.9% of second-lien term loans, 5.5% of subordinated notes in our CLO, 3.5% of syndicated loans and 4.3% of equity interest. The weighted average current yield was 10.8%, which was comprised of a weighted average current yield of 10.5% on first-lien term loan, 11.7% on second-lien, 5.4% on syndicated loans and 12.2% on our CLO subordinated notes. Despite downward pressure on yields due to continued competition, our yields have remained strong as compared to the previous fiscal quarters. To further illustrate this point, Slide 10 demonstrates how the yield on our core BDC assets, excluding our CLO and syndicated loans as well as our total assets yield, have remained consistently around 11% for the past several years. Following the originations and repayments during this quarter, the core BDC assets and also the syndicated loan’s yield increased slightly. This was offset by the CLO yields decreasing this quarter as it now includes the initial impact of the refinancing as well as the new investment in the CLO’s F note which has a rate of LIBOR plus 8.5%. All these changes resulted in the total yield of approximately 10.8%. Moving on to Slide 11, during the third quarter 2017, we made investments of $30.1 million in three new or existing portfolio companies and had $23.8 million in 3 exits and repayments, resulting in a net increase in investments of $6.3 million for the quarter at our BDC. As you can see on Slide 11, our investments continue to be highly diversified by type as well as in terms of geography and industry, with a large focus on business, consumer and healthcare services while spread over 11 distinct industries. It is worth noting that we have no direct exposure to the oil and gas industry, a fact that has served us extremely well during this past fiscal year. Of our total investment portfolio, 4.3% consist of equity interest. Equity investments are and will continue to be an important part of our overall investment strategy. As we discussed earlier, we have had consistent realized gains over the past years that has helped grow our NAV. Slide 12 demonstrates how realized gains from the sale of equity investments, combined with other investments, have helped enhance shareholder capital. For the past five fiscal years, we have had a combined $17.6 million of net realized gains from the sale of equity interest or sale of early redemption of other investments. This consistent performance continues to be a good indicator of our portfolio credit quality. In the third quarter 2017, we continued this trend and we are able to show a net realized gain of $0.3 million. Year-to-date fiscal 2017, total net realized gains are $12.3 million. That concludes my financial and portfolio review. I will now turn the call over to Michael Grisius, our President and Chief Investment Officer, for an overview of the investment market.